Health

BULLETIN ON COVID-19

Graph of daily covid-19 cases

Posted On: 18 AUGUST 2021, Delhi

Advertisements

IN PUBLIC INTEREST

*Cover your face with masks to prevent transmission of droplets carrying coronavirus
*Exercise social distancing
*Wash your hands frequently
*Sanitize your hands

STAY HOME & STAY SAFE!

 

https://i1.wp.com/static.pib.gov.in/WriteReadData/userfiles/image/image0020FX3.png?w=1300&ssl=1
https://i2.wp.com/static.pib.gov.in/WriteReadData/userfiles/image/image001BPSF.jpg?w=1300&ssl=1
56.06 Cr. vaccine doses have been administered so far under Nationwide Vaccination DriveIndia reports 35,178 new cases in last 24 hoursActive cases constitute 1.14% of total cases; lowest since March 2020India’s Active caseload currently 3,67,415; lowest in 148 daysRecovery Rate currently at 97.52%; Highest since March 20203,14,85,923 total recoveries across the country so far37,169 patients recovered during last 24 hoursWeekly Positivity Rate currently at 1.95%; less than 3% for last 54 daysDaily positivity rate at 1.96%; less than 3% for last 23 daysTesting capacity substantially ramped up – 49.84 crore tests conducted(Total)

#Unite2FightCorona#IndiaFightsCorona

PRESS INFORMATION BUREAU

MINISTRY OF INFORMATION & BROADCASTING

GOVERNMENT OF INDIA

Image

COVID-19 Update

India’s Cumulative COVID-19 Vaccination Coverage crossed 56 Crore landmark

Recovery Rate (97.52%) at its highest since March 2020

35,178 Daily New Cases reported in last 24 hours

India’s Active Caseload (3,67,415) lowest in 148 days

Active cases constitute 1.14% of total cases; lowest ever since March 2020

Daily Positivity Rate (1.96%) less than 3% for last 23 days

India’s COVID-19 vaccination coverage crossed 56 Cr landmark yesterday. Cumulatively, 56,06,52,030 vaccine doses have been administered through 62,67,149 sessions, as per the provisional report till 7 am today. 55,05,075 vaccine doses were administered in the last 24 hours.These include:

HCWs1st Dose1,03,51,471
2nd Dose81,39,176
FLWs1st Dose1,82,91,828
2nd Dose1,23,10,279
Age Group 18-44 years1st Dose20,53,38,194
2nd Dose1,66,89,475
Age Group 45-59 years1st Dose11,96,50,340
2nd Dose4,68,78,435
Over 60 years1st Dose8,20,88,223
2nd Dose4,09,14,609
Total56,06,52,030

The new phase of universalization of COVID-19 vaccination has commenced from 21st June, 2021. The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country.

India’s recovery rate stands at 97.52%, this is highest since March 2020.Out of the people infected since the beginning of the pandemic, 3,14,85,923 people have already recovered from COVID-19 and 37,169 patients have recovered in the last 24 hours.

https://i0.wp.com/static.pib.gov.in/WriteReadData/userfiles/image/image00134G6.jpg?w=1300&ssl=1

India has reported 35,178 daily new cases in the last 24 hours.

Less than 50,000 Daily New Cases have been reported since fifty-two consecutive days. This is a result of sustained and collaborative efforts by the Centre and the States/UTs.

https://i2.wp.com/static.pib.gov.in/WriteReadData/userfiles/image/image0029TD1.jpg?w=1300&ssl=1

India’s Active Caseload at 3,67,415 is lowest in 148 daysActive cases now constitute only 1.14% of the country’s total Positive Cases which is lowest since March 2020.

https://i0.wp.com/static.pib.gov.in/WriteReadData/userfiles/image/image003OB6A.jpg?w=1300&ssl=1

With substantially ramped up testing capacity across the country, a total of 17,97,559 tests were conducted in the last 24 hours in the country. Cumulatively, India has conducted over 49.84 crore (49,84,27,083) tests so far.

While on one side testing capacity has been enhanced across the country, Weekly Positivity Rate at 1.95% remains less than 3% for last 54 days now. The Daily Positivity rate also stands at 1.96%. Daily Positivity rate has remained below 3% for last 23 days and below 5% for 72 consecutive days now.

Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1746841

COVID-19 Vaccination Update

More than 57.88 Crore vaccine doses provided to States/UTs

More than 94 Lakh balance and unutilized doses still available with States/UTs and private hospitals to be administered

As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75% of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.

 VACCINE DOSES (As on 18 August 2021)
 SUPPLIED 57,88,90,150
 PIPELINE 18,62,530
 CONSUMPTION 55,11,64,635
 BALANCE AVAILABLE  94,03,637

More than 57.88 crore (57,88,90,150) vaccine doses have been provided to States/UTs so far, through all sources and a further 18,62,530 doses are in the pipeline.

Of this, the total consumption including wastages is 55,11,64,635 doses (as per data available at 8 AM today).

More than 94 Lakh (94,03,637) balance and unutilized COVID Vaccine doses are still available with the States/UTs and private hospitals to be administered.

Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1746849

“In future, recommendations for boosters will definitely come”

“Mix-and-match of vaccines will definitely not cause a safety issue”

“Wearing mask properly and actively encouraging everyone to get vaccinated are the two biggest weapons to control further waves”

Priya Abraham, National Institute of Virology Director speaks on scientific developments on COVID-19

ICMR-National Institute of Virology (NIV) in Pune has been working on a war-footing for the whole of last one year.  “2021 was a difficult but rewarding year for us”, said Ms. Priya Abraham, Director of ICMR-NIV, which has been at the forefront of scientific research on SARS-CoV-2 in the country. in an interview with India Science, the OTT channel of the Department of Science & Technology.

Giving a quick overview of vaccine development process carried out at the institute which has been at the forefront of scientific research on SARS-CoV-2 in the country, she explained: “We quickly isolated and gave a strain to Bharat Biotech International Limited (BBIL) by the end of April (2020), after which they developed a whole virion-inactivated vaccine in the month of May and gave us back for review.  We checked it for its complete inactivation, did its complete characterisation and started pre-clinical trials on hamsters and non-human primates, that is, monkeys. Those are very difficult experiments to do. These were conducted in our highest Bio-Safety Level-4 level containment facilities.  In the next phase, we assisted them in the Phase I, II and III clinical trials in areas such as diagnostic aspect and laboratory support”.

Details: https://pib.gov.in/PressReleasePage.aspx?PRID=1746864

Important Tweets

Categories: Health, National

Tagged as: ,

Leave a Reply